Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Cat-scratch disease (CSD) is an infectious disease caused by , presenting with fever and lymphadenopathy following contact with felines. The ocular manifestations include neuroretinitis, characterised by optic nerve swelling and a macular star. Case Presentation: We discuss a case of neuroretinitis that presented atypically, without a macular star. There was an initial suspicion of , but the serology was negative. Our patient was eventually empirically treated for infective neuroretinitis based on a positive contact history (recently scratched by one of his three pet cats). There was progression to a macular star upon serial dilated fundus examination, and the repeated serology one week after symptom onset showed rising titres, supporting a diagnosis of CSD. Conclusions: A judicious review of systems, repeat assays, serial dilated fundus examination, and early ophthalmic evaluation are useful in cases of suspected neuroretinitis, remaining an important differential in the evaluation of sudden-onset painless vision loss and unilateral disc swelling.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11359919PMC
http://dx.doi.org/10.3390/tropicalmed9080186DOI Listing

Publication Analysis

Top Keywords

macular star
16
star case
8
serial dilated
8
dilated fundus
8
fundus examination
8
neuroretinitis
5
neuroretinitis initial
4
initial seronegativity
4
seronegativity absent
4
macular
4

Similar Publications

Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.

Lancet

July 2025

Faculty of Life Sciences and Medicine, King's College London, London WC2R 2LS, UK; King's Ophthalmology Research Unit, King's College Hospital, London, UK.

View Article and Find Full Text PDF

Retinal diseases, such as age-related macular degeneration and diabetic macular edema, are significant contributors to vision loss. While injection of anti-vascular endothelial growth factors is the current gold standard treatment, their invasive nature reduces patient compliance and treatment outcomes and increases the risk of complications. In this review, we explore the recent advancements in drug delivery systems designed to overcome ocular barriers to effectively deliver drugs to the retina.

View Article and Find Full Text PDF

Background: A post hoc analysis of the STAR study, which was a 48-week, phase IV, multicenter randomized controlled multicenter clinical trial was performed. This study aims to identify the baseline factors associated with visual and anatomic changes over 48 weeks in the treatment of active polypoidal choroidal vasculopathy (PCV) with conbercept.

Methods: In the STAR study, 249 participants were randomized to either the 3 + Q12W (3 monthly injections followed by injections every 12 weeks) or 3 + TAE (3 monthly injections followed by treat and extend regimen) group.

View Article and Find Full Text PDF